Summary
RED ONE PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €404,921 and a net result of €128,022. Equity is growing by ~28.3% per year across the filed fiscal years. The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
43 d early
2024
42 d early
2023
30 d early
2022
46 d early
2021
45 d early
2020
43 d early
2019
42 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 42 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema, 2025 accounts filed, figures not processed yet
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€128,022▼ 7.1%
2023 · €137,861
Working capital
€28,051▼ 85.2%
2023 · €189,850
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€50,438▼ 10.1%€49,497▼ 1.9%€46,677▼ 5.7%€34,668▼ 25.7%€27,593▼ 20.4%
Net result€143,874above the sector's middle half▲ 401%€143,209above the sector's middle half▼ 0.5%€134,024above the sector's middle half▼ 6.4%€137,861above the sector's middle half▲ 2.9%€128,022above the sector's middle half▼ 7.1%
Equity€201,806within the sector's middle half▲ 248%€345,015within the sector's middle half▲ 71.0%€479,038within the sector's middle half▲ 38.8%€516,900within the sector's middle half▲ 7.9%€404,921within the sector's middle half▼ 21.7%
Total assets€1.1mwithin the sector's middle half▲ 8.0%€1.2mwithin the sector's middle half▲ 3.0%€1.2mwithin the sector's middle half▲ 7.0%€1.3mwithin the sector's middle half▲ 6.3%€1.1mwithin the sector's middle half▼ 13.2%
Debt€915,664▼ 6.3%€806,163▼ 12.0%€752,878▼ 6.6%€792,611▲ 5.3%€731,098▼ 7.8%
Working capital€17,487within the sector's middle half€114,146within the sector's middle half▲ 553%€200,649within the sector's middle half▲ 75.8%€189,850within the sector's middle half▼ 5.4%€28,051within the sector's middle half▼ 85.2%
Solvency18.1%within the sector's middle half▲ 12.5pp30.0%within the sector's middle half▲ 11.9pp38.9%within the sector's middle half▲ 8.9pp39.5%within the sector's middle half▲ 0.6pp35.6%within the sector's middle half▼ 3.8pp
Current ratio1.13within the sector's middle half▲ 0.712.50above the sector's middle half▲ 1.373.53above the sector's middle half▲ 1.032.07within the sector's middle half▼ 1.461.16within the sector's middle half▼ 0.91
Return on assets (ROA)12.9%above the sector's middle half▲ 10.1pp12.4%above the sector's middle half▼ 0.4pp10.9%above the sector's middle half▼ 1.6pp10.5%above the sector's middle half▼ 0.4pp11.3%above the sector's middle half▲ 0.7pp
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result has fallen four years in a row; 2024 is 20% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.1m
Fixed assets
€934,053 ▼ 1.0%
Current assets
€201,967 ▼ 44.9%
Equity and liabilities €1.1m
Equity
€404,921 ▼ 21.7%
Debt
€731,098 ▼ 7.8%
Debt's share of the balance-sheet total rises from 60.5% to 64.4%. Equity and debt are lower.
Key figures and ratios
ROE
31.6%▲
2023 · 26.7%
Debt ≤ 1 year
€173,916▼
2023 · €176,645
Debt > 1 year
€557,182▼
2023 · €615,966
Income taxes
€3,801▼
2023 · €4,832
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €8,652 | €8,963 | €8,963 | €8,963 | €8,963 | = |
| Other operating charges640/8 | - | €2,024 | €2,052 | €2,539 | €3,534 | ▲ 39.2% |
| Gross operating margin9900 | €61,255 | €60,483 | €57,691 | €46,170 | €40,089 | ▼ 13.2% |
| Operating profit (loss)9901 | €50,438 | €49,497 | €46,677 | €34,668 | €27,593 | ▼ 20.4% |
| Financial income75/76B | - | €120,003 | €122,077 | €111,087 | €121,051 | ▲ 9.0% |
| Recurring financial income75 | €120,231 | €120,003 | €122,077 | €111,087 | €121,051 | ▲ 9.0% |
| Financial charges65/66B | - | €20,132 | €27,513 | €3,062 | €16,822 | ▲ 449% |
| Recurring financial charges65 | €20,820 | €20,132 | €27,513 | €3,062 | €16,822 | ▲ 449% |
| Profit (loss) for the period before taxes9903 | €149,849 | €149,367 | €141,241 | €142,693 | €131,822 | ▼ 7.6% |
| Income taxes67/77 | €5,976 | €6,158 | €7,217 | €4,832 | €3,801 | ▼ 21.3% |
| Profit (loss) for the period9904 | €143,874 | €143,209 | €134,024 | €137,861 | €128,022 | ▼ 7.1% |
| Profit (loss) for the period to be appropriated9905 | €143,874 | €143,209 | €134,024 | €137,861 | €128,022 | ▼ 7.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.1m | €1.2m | €1.2m | €1.3m | €1.1m | ▼ 13.2% |
| Fixed assets21/28 | €969,904 | €960,941 | €951,978 | €943,015 | €934,053 | ▼ 1.0% |
| Tangible fixed assets22/27 | €275,572 | €266,609 | €257,646 | €248,683 | €239,721 | ▼ 3.6% |
| Land and buildings22 | - | €264,909 | €256,409 | €247,910 | €239,410 | ▼ 3.4% |
| Furniture and vehicles24 | - | €1,699 | €1,237 | €774 | €311 | ▼ 59.8% |
| Financial fixed assets28 | €694,332 | €694,332 | €694,332 | €694,332 | €694,332 | = |
| Current assets29/58 | €147,566 | €190,237 | €279,938 | €366,495 | €201,967 | ▼ 44.9% |
| Amounts receivable within one year40/41 | €77,833 | €33,889 | €123,317 | €143,954 | €22,760 | ▼ 84.2% |
| Other amounts receivable41 | - | €33,889 | €123,317 | €143,954 | €22,760 | ▼ 84.2% |
| Current investments50/53 | €27,007 | €69,007 | €107,243 | €179,007 | €55,535 | ▼ 69.0% |
| Cash at bank and in hand54/58 | €42,725 | €86,849 | €48,884 | €43,064 | €23,051 | ▼ 46.5% |
| Deferred charges and accrued income490/1 | - | €491 | €494 | €472 | €100,620 | ▲ 21,240% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.1m | €1.2m | €1.2m | €1.3m | €1.1m | ▼ 13.2% |
| Equity10/15 | €201,806 | €345,015 | €479,038 | €516,900 | €404,921 | ▼ 21.7% |
| Contributions10/11 | - | €40,000 | €40,000 | €40,000 | €40,000 | = |
| Profit (loss) carried forward14 | €161,806 | €305,015 | €439,038 | €476,900 | €364,921 | ▼ 23.5% |
| Amounts payable17/49 | €915,664 | €806,163 | €752,878 | €792,611 | €731,098 | ▼ 7.8% |
| Amounts payable after more than one year17 | €785,440 | €730,072 | €673,588 | €615,966 | €557,182 | ▼ 9.5% |
| Financial debts170/4 | - | €730,072 | €673,588 | €615,966 | €557,182 | ▼ 9.5% |
| Amounts payable within one year42/48 | €130,079 | €76,091 | €79,289 | €176,645 | €173,916 | ▼ 1.5% |
| Current portion of amounts payable after more than one year42 | - | €55,368 | €56,484 | €57,622 | €58,784 | ▲ 2.0% |
| Financial debts43 | - | €7,500 | €7,500 | €7,500 | €2,500 | ▼ 66.7% |
| Credit institutions430/8 | - | €7,500 | €7,500 | €7,500 | €2,500 | ▼ 66.7% |
| Trade debts44 | €530 | €0 | €53 | €174 | €1,064 | ▲ 512% |
| Suppliers440/4 | - | €0 | €53 | €174 | €1,064 | ▲ 512% |
| Taxes, remuneration and social security45 | - | €8,002 | €6,107 | €8,017 | €8,031 | ▲ 0.2% |
| Taxes450/3 | - | €8,002 | €6,107 | €8,017 | €8,031 | ▲ 0.2% |
| Other amounts payable47/48 | - | €5,221 | €9,146 | €103,331 | €103,536 | ▲ 0.2% |
| Accrued charges and deferred income492/3 | - | €0 | - | - | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €143,874 | €143,209 | €134,024 | €137,861 | €128,022 | ▼ 7.1% |
| + Depreciation and write-downs630 | €8,652 | €8,963 | €8,963 | €8,963 | €8,963 | = |
| Operating cash flow (approximation) | €152,525 | €152,172 | €142,987 | €146,824 | €136,984 | ▼ 6.7% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | €44,124 | -€37,965 | -€5,820 | -€20,013 | ▼ 244% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
19-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Equity above €500,000Eq €516,900 ▲7.9%
5 profitable years in a row build equity to €516,900.
15-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
16-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Liquidity doublescurrent ratio 2.50
Current ratio from 1.13 to 2.50; short-term debt falls from €130,079 to €76,091.
18-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Highest result since 2018net €143,874 ▲401%
Net result €143,874, the highest in the series.
31-12
Financial
Liquidity triplescurrent ratio 1.13
Current ratio from 0.43 to 1.13; short-term debt falls from €137,002 to €130,079.
31-12
Financial
Equity above €200,000Eq €201,806 ▲248%
2 profitable years in a row build equity to €201,806.
19-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Back to profitnet €28,727
Net result €28,727 after one loss-making year.
10-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 2 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2017
Ground area
83 m²
Building footprint
56 m²
Volume, LiDAR
560 m³
Parcel 21815D0257/00F002, Brussels · tallest building 14.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
RED ONE PHARMA
since 20172.270.258.472
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21815D0257/00F002 | Brussels | 83 m² | 1 · 56 m² | 14.6 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2024 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2024 annual accounts of RED ONE PHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
PHARMACIE G. DENEF
BE 0464.469.355
Binche · Eq €404,848
PHARMACIE GRAND'MAZURES
BE 0477.868.817
Tournai · Eq €404,815
APOTHEEK VAN DAMME CAROLINE
BE 0845.592.055
Waasmunster · Eq €404,686
APOTHEEK DE SWEEMER
BE 0421.084.918
Gent · Eq €404,641
PHARMACIE ALEN
BE 0473.939.525
Liège · Eq €405,370
Of 5,219 companies in this sector we hold annual accounts for 3,862. 3,427 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded16-11-2017
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
64210Activities of holding companies
68203Renting and operating of own or leased non-residential real estate, excluding land
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0684757741
Also
0208:684757741
Also
9925:BE0684757741
Registered
19-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.